5 Peripheral T-Cell Lymphoma Clinical Trials in Boston, MA (2026)

Q: How do I join a clinical trial in Boston?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you.

Recruiting Peripheral T-Cell Lymphoma Studies in Boston

NCT06561048Recruiting

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

A Phase 3, randomized, 2-arm, open-label, multicenter, stratified study of soquelitinib versus physician's choice standard of care (SOC) treatment (selected single agents) in participants with relapse...

Boston, MAPHASE3150 participantsCorvus Pharmaceuticals, Inc.

View Study Details

NCT07192471Recruiting

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

The purpose of this study is to determine the safety, tolerability, PK and pharmacodynamics of KK2223 in adult participants with relapsed or refractory peripheral T cell lymphoma (PTCL) or cutaneous T...

Boston, MAPHASE172 participantsKyowa Kirin, Inc.

View Study Details

NCT05010005Recruiting

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

This study will test the safety of ruxolitinib, given at one dose that does not change, and duvelisib, given at different doses, to find out what effects, if any, the study treatment has on people wit...

Boston, MAPHASE170 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06534060Recruiting

MB-105 in Patients With CD5 Positive T-cell Lymphoma

This is a single arm, two-stage, Phase 2, open-label, multicenter study of MB-105 in patients with CD5 Positive (CD5+) Relapsed / Refractory T-cell Lymphoma (r/r TCL). This study will apply a Simon tw...

Boston, MAPHASE246 participantsMarch Biosciences Inc

View Study Details

NCT05313243Recruiting

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

This is a single arm, open label, multicenter study phase 2 study of pembrolizumab and brentuximab in subjects with relapsed/refractory CD30 positive T-cell lymphoma (including peripheral T-cell lymph...

Boston, MAPHASE232 participantsYale University

View Study Details

About Peripheral T-Cell Lymphoma Clinical Trials in Boston

Peripheral T-cell lymphomas are a diverse group of aggressive non-Hodgkin lymphomas that develop from mature T-cells. They account for about 10-15% of all NHL cases. Treatment includes combination chemotherapy, stem cell transplant, and newer targeted agents.

There are currently 5 peripheral t-cell lymphoma clinical trials recruiting participants in Boston, MA. These studies are seeking a combined 370 participants. Research is being sponsored by Corvus Pharmaceuticals, Inc., Kyowa Kirin, Inc., Memorial Sloan Kettering Cancer Center and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Peripheral T-Cell Lymphoma Clinical Trials in Boston — FAQ

Are there peripheral t-cell lymphoma clinical trials in Boston?

Yes, there are 5 peripheral t-cell lymphoma clinical trials currently recruiting in Boston, MA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Boston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.

Are clinical trials in Boston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.

What peripheral t-cell lymphoma treatments are being tested?

The 5 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral t-cell lymphoma.

Data updated October 15, 2026 from ClinicalTrials.gov